Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
Although it is important to recognize that, just as the rise in obesity has been driven by multiple interacting factors, its recent decline is also likely shaped by a complex interplay of causes
It is identified in the clinical-research literature under the development designation LY3437943 and is currently in Phase 3 evaluation under the TRIUMPH trial program
Insurance approval can also depend on BMI documentation
And if insurance companies see significant cost increases because of the popularity of a new drug, that cost gets passed along in higher premiumswhich already grow at a frustrating rate year-after-year
US$ 24.05
US$ 24.81
US$ 27.94
US$ 21.16
US$ 27.96
US$ 26.57
US$ 25.77
